Clinical Trial Update: Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pelvic or vaginal implant radiation therapy with paclitaxel and carboplatin for high-risk stage I/II endometrial cancer; status/results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Pelvic Radiation Therapy
• Vaginal Implant Radiation Therapy

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma | Phase 3 | Status: UNKNOWN | Results posted: 2018-04-27